NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/22/2024
Back to search
Official data from USPTO
TRINTELLIX VORTIOXETINE TABLETS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
10/22/2024
Trademark type
Combined
Nice classes
5
Filing date
12/20/2023
Registration date
10/22/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/22/2024
Last transaction
10/22/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/02/2016
First use in commerce
05/02/2016
Drawing code
3
Owner type
99
Owner location
Valby, DK
Examiner
CHONG, JESSICA
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized characters "TRINTELLIX" in blue-green and the dot over the first letter "I" represented by concentric orange circles where an upper portion of each circle is faded out, all on a white background. The wording "VORTIOXETINE" and "TABLETS" in stylized blue-green font is placed below the word "TRINTELLIX". Below the wording is a blue-green color block design forming the shape of a partial square, with a curved line sloping downward from the top left of the square to the lower right portion of the square.
Holders and representatives
Holders
H. Lundbeck A/S
Representatives
Maren C. Perry King & Spalding LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases ingenerated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of depressioncognitive disordersmood disorders; pharmaceuticals for treatment of cognitive disorders and diseases
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/22/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/06/2024
PUBO
PUBLISHED FOR OPPOSITION
08/06/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/17/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/01/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/01/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/25/2024
GNRT
NON-FINAL ACTION E-MAILED
06/25/2024
CNRT
NON-FINAL ACTION WRITTEN
06/25/2024
DOCK
ASSIGNED TO EXAMINER
06/25/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/01/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/01/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/22/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
03/22/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/22/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/22/2024
NWAP
NEW APPLICATION ENTERED
12/20/2023
Continuous trademark protection
Get notified about every new filing that threatens TRINTELLIX VORTIOXETINE TABLETS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.